In a landmark lawsuit that could have far-reaching implications for the future of medical innovation, Hexagon Health, a company founded by Dr. Shirin Towfigh, has filed a patent infringement case against Medtronic, accusing the global medical device giant of copying her patented hernia mesh design. The case has drawn attention to the ongoing issue of intellectual property theft in the medtech industry and highlights the vulnerabilities faced by physician-entrepreneurs in bringing new medical technologies to market.
Founded in 2015, Hexagon Health was born out of Dr. Towfigh’s extensive experience as a surgeon specializing in abdominal and pelvic health, particularly hernia repairs. Dr. Towfigh, who is also a practicing surgeon in Beverly Hills, has developed a novel hernia mesh with a unique fin-like shape designed to reduce complications that commonly arise in hernia surgery.
Her work focuses on improving outcomes for both men and women, addressing the gaps in traditional hernia care. Men often face complications from inguinal hernia mesh, such as nerve damage and painful intercourse, while women, who are more likely to suffer from femoral hernias, benefit from Dr. Towfigh’s design, which improves coverage in the femoral area and reduces the risk of life-threatening complications.
Dr. Towfigh’s innovative mesh designs have earned her nine patents, filed between 2015 and 2021, securing her intellectual property in the competitive field of hernia treatment.
The lawsuit, filed in California, claims that Medtronic’s hernia mesh product, Dextile, is strikingly similar to Dr. Towfigh’s patented design. The complaint alleges that Medtronic took Dr. Towfigh’s ideas and proprietary designs after years of discussions and negotiations, ultimately incorporating them into Dextile without permission.
According to the complaint, Dr. Towfigh had multiple meetings with Medtronic’s leadership, including a visit to Medtronic’s manufacturing facility in France. These discussions were centered around potential collaboration to bring Dr. Towfigh’s mesh product to market, yet Medtronic filed a patent for a similar product in 2017. The complaint claims that the Medtronic product features a fin-like shape that mirrors the unique characteristics of Hexagon’s design.
Medtronic has responded by saying it is actively reviewing the lawsuit but has emphasized its long-standing commitment to respecting intellectual property rights.
This case represents more than just a legal dispute; it underscores a pervasive problem in the medtech industry — the exploitation of physician-innovators by larger, more resourceful companies. Dr. Towfigh’s concerns reflect the broader challenges faced by medical professionals who seek to improve patient care through innovation but find themselves up against massive corporations with the power to challenge patents and drag inventors into lengthy and expensive legal battles.
Peter Sullivan, a patent attorney not involved in the case, pointed out that the unique aspect of this lawsuit is not just the claim of patent infringement, but Dr. Towfigh’s effort to be recognized as a co-inventor on the Medtronic patents. “This isn’t just about compensation for patent infringement; it’s about rightful acknowledgment of innovation,” Sullivan said.
Dr. Towfigh’s attorney, Nicholas Groombridge, also emphasized the broader implications of the case. “Medtronic’s alleged actions have caused significant harm to Dr. Towfigh’s business and created a disincentive for other physician-entrepreneurs to enter the medical device market,” Groombridge said. “This pattern of exploiting physician-created innovations without proper compensation threatens the future of healthcare advancements.”
Dr. Towfigh’s lawsuit serves as a cautionary tale for other physician-entrepreneurs looking to collaborate with large industry players. It highlights the critical importance of patent protection, the potential risks of sharing proprietary ideas, and the ethical obligations of corporations to uphold the trust of the medical community.
“There is a sacred relationship between physicians and the industry, particularly for surgeons who work directly with patients and see firsthand the need for better solutions,” Dr. Towfigh said. “But when the trust in these partnerships is broken, it not only harms the individual inventor but also undermines the potential for meaningful progress in medical care.”
While the case is still in its early stages, legal experts expect the dispute to undergo several phases. Medtronic is likely to challenge Hexagon’s patents and may attempt to invalidate them. However, even if the patents are invalidated, Dr. Towfigh’s claim to be listed as a co-inventor on Medtronic’s product could still proceed independently.
As Dr. Towfigh’s lawyer, Groombridge, noted, this case is not just about financial compensation; it’s about ensuring that physician-innovators are properly recognized for their contributions to medical advancements. The outcome of this case may set a precedent for how patent infringement and physician innovation are handled in the future.
This lawsuit is not the first time Medtronic has faced accusations of patent infringement. In previous cases, such as a 2014 lawsuit by Dr. Mark Barry over spinal device patents, Medtronic was found to have infringed on intellectual property, resulting in a multi-million-dollar settlement. These recurring allegations raise questions about the company’s practices and its approach to protecting intellectual property in the healthcare sector.
Dr. Towfigh’s legal battle with Medtronic is far from over, but it shines a light on a pressing issue: the need for greater protection for physician-entrepreneurs and the ethical responsibilities of large corporations in the medtech industry. The outcome of this case could shape the future of medical innovation and set new standards for how ideas in healthcare are protected, recognized, and respected.
READ MORE: